<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36833793</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>10</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Personalized Computerized Training for Cognitive Dysfunction after COVID-19: A Before-and-After Feasibility Pilot Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3100</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph20043100</ELocationID><Abstract><AbstractText>The current pilot study was set to evaluate the feasibility and potential benefit of a personalized computerized cognitive training (CCT) intervention to improve cognitive function among people living with post-acute sequelae of COVID-19 (PASC). Seventy three adults who self-reported cognitive dysfunction more than 3 months after a diagnosis of COVID-19 took part in an 8-week training study. Participants' general cognitive function was assessed before they completed as many cognitive daily training sessions as they wished during an 8-week period, using a personalized CCT application at home. At the end of this period, participants repeated the general cognitive function assessment. The differences between the scores at 8 weeks and baseline in five cognitive domains (attention, memory, coordination, perception, reasoning), complemented with analyses of the changes based on the participants' age, training time, self-reported health level at baseline and time since the initial COVID-19 infection. Participants had significant cognitive dysfunction and self-reported negative health levels at baseline. Most of the participants obtained higher scores after CCT in each of the domains as compared with baseline. The magnitude of this score increase was high across domains. It is concluded that a self-administered CCT based on gamified cognitive tasks could be an effective way to ameliorate cognitive dysfunction in persons with PASC. The ClinicalTrials.gov identifier is NCT05571852.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du&#xf1;abeitia</LastName><ForeName>Jon Andoni</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-3312-8559</Identifier><AffiliationInfo><Affiliation>AcqVA Aurora Center, Department of Languages and Culture, UiT the Arctic University of Norway, 9019 Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Nebrija en Cognici&#xf3;n (CINC), Facultad de Lenguas y Educaci&#xf3;n, Universidad Nebrija, 28248 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mera</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unidad Long COVID y S&#xed;ndromes Postvirales, Blue Health Care, 28036 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baro</LastName><ForeName>&#xd3;scar</ForeName><Initials>&#xd3;</Initials><AffiliationInfo><Affiliation>Centro de Salud de Galapagar, 28260 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadad-Garcia</LastName><ForeName>Tamen</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Vivenxia Group, Beverly Hills, CA 90210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadad</LastName><ForeName>Alejandro R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Centre for Digital Therapeutics, Toronto, ON M5G 2C4, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05571852</AccessionNumber></AccessionNumberList></DataBank><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.21908571</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">computerized cognitive training</Keyword><Keyword MajorTopicYN="N">digital therapeutics</Keyword><Keyword MajorTopicYN="N">pandemics</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36833793</ArticleId><ArticleId IdType="pmc">PMC9966004</ArticleId><ArticleId IdType="doi">10.3390/ijerph20043100</ArticleId><ArticleId IdType="pii">ijerph20043100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuschke D., Houston D. The impact of Long COVID on the UK workforce. Appl. Econ. Lett. 2022;10:2577. doi: 10.1080/13504851.2022.2098239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13504851.2022.2098239</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing Long COVID: Deep Phenotype of a Complex Condition. EBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., Suen J., Robba C., Fraser J., Cho S.M. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J. Neurol. Sci. 2022;434:120162. doi: 10.1016/j.jns.2022.120162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators Estimated Global Proportions of Individuals with Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention  Long COVID or Post-COVID Conditions.  [(accessed on 25 September 2022)];2022  Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. 2021.  [(accessed on 25 September 2022)].  Available online:  https://www.nice.org.uk/guidance/NG188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization  In the Wake of the Pandemic Preparing for Long COVID. 2021.  [(accessed on 25 September 2022)].  Available online:  https://apps.who.int/iris/bitstream/handle/10665/339629/Policy-brief-39-1997-8073-eng.pdf.</Citation></Reference><Reference><Citation>Chasco E.E., Dukes K., Jones D., Comellas A.P., Hoffman R.M., Garg A. Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID. Int. J. Environ. Res. Public Health. 2022;19:15499. doi: 10.3390/ijerph192315499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192315499</ArticleId><ArticleId IdType="pmc">PMC9737348</ArticleId><ArticleId IdType="pubmed">36497573</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan K., Lin Y., Prewitt K.M., Potter D.A. Multidisciplinary Approach to Brain Fog and Related Persisting Symptoms Post COVID-19. J. Health Serv. Psychol. 2022;48:31&#x2013;38. doi: 10.1007/s42843-022-00056-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42843-022-00056-7</ArticleId><ArticleId IdType="pmc">PMC8809226</ArticleId><ArticleId IdType="pubmed">35128461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long-COVID treatments: Why the world is still waiting. Nature. 2022;608:258&#x2013;260. doi: 10.1038/d41586-022-02140-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02140-w</ArticleId><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavelin H.M., Domell&#xf6;f M.E., Leung I., Neely A.S., Launder N.H., Nategh L., Finke C., Lampit A. Computerized cognitive training in Parkinson&#x2019;s disease: A systematic review and meta-analysis. Ageing Res. Rev. 2022;80:101671. doi: 10.1016/j.arr.2022.101671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2022.101671</ArticleId><ArticleId IdType="pubmed">35714854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Feng H., Li G., Xu C., Wu Y., Li H. Efficacy of computerized cognitive training on improving cognitive functions of stroke patients: A systematic review and meta-analysis of randomized controlled trials. Int. J. Nurs. Pr. 2021;28:e12966. doi: 10.1111/ijn.12966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijn.12966</ArticleId><ArticleId IdType="pubmed">34036682</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahar-Fuchs A., Barendse M.E.A., Bloom R., Ravona-Springer R., Heymann A., Dabush H., Bar L., Slater-Barkan S., Rassovsky Y., Schnaider Beeri M. Computerized Cognitive Training for Older Adults at Higher Dementia Risk due to Diabetes: Findings from a Randomized Controlled Trial. J. Gerontol. A Biol. Sci. Med. Sci. 2020;75:747&#x2013;754. doi: 10.1093/gerona/glz073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glz073</ArticleId><ArticleId IdType="pmc">PMC7931965</ArticleId><ArticleId IdType="pubmed">30868154</ArticleId></ArticleIdList></Reference><Reference><Citation>Embon-Magal S., Krasovsky T., Doron I., Asraf K., Haimov I., Gil E., Agmon M. The effect of co-dependent (thinking in motion [TIM]) versus single-modality (CogniFit) interventions on cognition and gait among community-dwelling older adults with cognitive impairment: A randomized controlled study. BMC Geriatr. 2022;22:720. doi: 10.1186/s12877-022-03403-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-022-03403-x</ArticleId><ArticleId IdType="pmc">PMC9429752</ArticleId><ArticleId IdType="pubmed">36045345</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for Health Improvement &amp; Disparities of the Department of Health and Social Care  Before-and-after Study: Comparative Studies.  [(accessed on 25 September 2022)];2020  Available online:  https://www.gov.uk/guidance/before-and-after-study-comparative-studies.</Citation></Reference><Reference><Citation>Lancaster G.A., Thabane L. Guidelines for reporting non-randomised pilot and feasibility studies. Pilot Feasibility Stud. 2019;5:114. doi: 10.1186/s40814-019-0499-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40814-019-0499-1</ArticleId><ArticleId IdType="pmc">PMC6778655</ArticleId><ArticleId IdType="pubmed">31608150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J., Humkamp K., Hohenfeld C., Rust M.I., Ermis U., Dreher M., Hartmann N.K., Marx G., Binkofski F., Finke C., et al. Long COVID-19: Objectifying most self-reported neurological symptoms. Ann. Clin. Transl. Neurol. 2022;9:141&#x2013;154. doi: 10.1002/acn3.51496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Buades-Sitjar F., Du&#xf1;abeitia J.A. Intelligence subcomponents and their relationship to general knowledge. J. Cult. Cogn. Sci. 2022;6:343&#x2013;355. doi: 10.1007/s41809-022-00113-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41809-022-00113-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaneva A., Massaldjieva R., Mateva N. Initial Adaptation of the General Cognitive Assessment Battery by Cognifit&#x2122; for Bulgarian Older Adults. Exp. Aging Res. 2021;48:336&#x2013;350. doi: 10.1080/0361073X.2021.1981096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0361073X.2021.1981096</ArticleId><ArticleId IdType="pubmed">34605370</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamovi. 2021.  [(accessed on 3 December 2022)].  Version 1.6; The Jamovi Project; Computer Software. Available online:  https://www.jamovi.org/</Citation></Reference><Reference><Citation>Sim J., Lewis M. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J. Clin. Epidemiol. 2012;65:301&#x2013;308. doi: 10.1016/j.jclinepi.2011.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.07.011</ArticleId><ArticleId IdType="pubmed">22169081</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2021;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600. doi: 10.1016/j.bbi.2020.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J.L., Nelson R.A., Thomason M.E., Sternberg D.A., Katovich K., Farzin F., Scanlon M. Enhancing Cognitive Abilities with Comprehensive Training: A Large, Online, Randomized, Active-Controlled Trial. PLoS ONE. 2015;10:e0134467. doi: 10.1371/journal.pone.0134467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0134467</ArticleId><ArticleId IdType="pmc">PMC4557999</ArticleId><ArticleId IdType="pubmed">26333022</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46:2235&#x2013;2240. doi: 10.1038/s41386-021-00978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., Schmiedel S., Addo M.M., Gerloff C., Heesen C., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2:fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen D.J., Kreuter M., Spring B., Cofta-Woerpel L., Linnan L., Weiner D., Bakken S., Kaplan C.P., Squiers L., Fabrizio C., et al. How we design feasibility studies. Am. J. Prev. Med. 2009;36:452&#x2013;457. doi: 10.1016/j.amepre.2009.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amepre.2009.02.002</ArticleId><ArticleId IdType="pmc">PMC2859314</ArticleId><ArticleId IdType="pubmed">19362699</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>